OnKure Therapeutics, Inc. — All Filings
345 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001558370-22-004158 | Mar 23, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001558370-22-004156 | Mar 23, 2022 | — |
| 8-K | 8-K | 0001193125-22-068011 | Mar 7, 2022 | Mar 2, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-016541 | Mar 4, 2022 | Mar 2, 2022 |
| 8-K | 8-K | 0001193125-22-025697 | Feb 2, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-019678 | Jan 27, 2022 | — |
| SC 13G | SC 13G | 0001193125-22-018295 | Jan 26, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-004627 | Jan 24, 2022 | Jan 20, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-004624 | Jan 24, 2022 | Jan 20, 2022 |
| 8-K | 8-K | 0001193125-22-016015 | Jan 24, 2022 | Jan 18, 2022 |
| 8-K | 8-K | 0001193125-21-367001 | Dec 27, 2021 | Dec 23, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-069448 | Dec 14, 2021 | Dec 10, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-069443 | Dec 14, 2021 | Dec 10, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-069439 | Dec 14, 2021 | Dec 10, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-069436 | Dec 14, 2021 | Dec 10, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-064587 | Nov 15, 2021 | Nov 12, 2021 |
| 10-Q | 10-Q | 0001558370-21-015674 | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0001558370-21-015672 | Nov 12, 2021 | Nov 11, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-21-060474 | Oct 14, 2021 | Oct 11, 2020 |
| 8-K | 8-K | 0001193125-21-296205 | Oct 12, 2021 | Oct 11, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-053523 | Aug 26, 2021 | Aug 25, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-053522 | Aug 26, 2021 | Aug 25, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-053520 | Aug 26, 2021 | Aug 25, 2021 |
| 8-K | 8-K | 0001558370-21-011217 | Aug 11, 2021 | — |
| 10-Q | 10-Q | 0001558370-21-011213 | Aug 11, 2021 | Jun 30, 2021 |
| 8-K | 8-K | 0001558370-21-011209 | Aug 11, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-046803 | Jul 15, 2021 | Jul 14, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-046802 | Jul 15, 2021 | Jul 14, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-046254 | Jul 9, 2021 | Jul 8, 2021 |
| 4 | — | 0000905718-21-000834 | Jun 25, 2021 | Jun 23, 2021 |
| 4 | — | 0000905718-21-000816 | Jun 23, 2021 | Jun 21, 2021 |
| 4 | — | 0000905718-21-000770 | Jun 10, 2021 | Jun 8, 2021 |
| 4 | — | 0000905718-21-000760 | Jun 7, 2021 | Jun 3, 2021 |
| 4 | — | 0000905718-21-000744 | Jun 2, 2021 | May 28, 2021 |
| 4 | — | 0000905718-21-000738 | May 28, 2021 | May 26, 2021 |
| 4/A | FORM 4/A SUBMISSION | 0001209191-21-036015 | May 26, 2021 | Apr 8, 2021 |
| 10-Q | 10-Q | 0001558370-21-007568 | May 20, 2021 | Mar 31, 2021 |
| 8-K | 8-K | 0001558370-21-007566 | May 20, 2021 | — |
| 8-K | 8-K | 0001193125-21-161994 | May 14, 2021 | May 11, 2021 |
| SC 13D | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D | 0001072613-21-000379 | Apr 23, 2021 | — |
| SC 13D | SC 13D | 0000905718-21-000606 | Apr 20, 2021 | — |
| SC 13D | SC 13D | 0001193125-21-120962 | Apr 19, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-026862 | Apr 15, 2021 | Apr 13, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-026826 | Apr 15, 2021 | Apr 13, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-026823 | Apr 15, 2021 | Apr 13, 2021 |
| 3/A | FORM 3/A SUBMISSION | 0001209191-21-026820 | Apr 15, 2021 | Apr 8, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-026817 | Apr 15, 2021 | Apr 13, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-026667 | Apr 14, 2021 | Apr 13, 2021 |
| SC 13D | SC 13D | 0001193125-21-116375 | Apr 14, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-015634 | Apr 13, 2021 | Apr 9, 2021 |